
CHEMOCENTRYX INC
Share · US16383L1061 · CCXI · A0NBM2 (XNAS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -13,34 % |
Company Profile for CHEMOCENTRYX INC Share
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.
Invested Funds
The following funds have invested in: CHEMOCENTRYX INC invested:
Fund | Vol. in million 39,09 | Percentage (%) 0,09 % |
Company Data
Name CHEMOCENTRYX INC
Company ChemoCentryx, Inc.
Symbol CCXI
Website
https://www.chemocentryx.com
Primary Exchange
NASDAQ

WKN A0NBM2
ISIN US16383L1061
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Thomas Schall
Country United States of America
Currency USD
Employees 0,2 T
Address 850 Maude Ave, 94070 Mountain View
IPO Date 2012-02-08
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | CCXI |
More Shares
Investors who CHEMOCENTRYX INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.